|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
36.500 -0.600 (-1.617%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 4,556,380 | 6.714% | 4,269,729 | 3,843,819 | 1,047,525 | 9,477 | |
| Cost of Sales | (930,990) | 84.232% | (505,337) | (387,761) | (124,878) | -- | |
| Gross Profit | 3,625,390 | -3.693% | 3,764,392 | 3,456,058 | 922,647 | -- | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (57,187) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (2,170,469) | -17.839% | (2,641,717) | (858,713) | (1,719,950) | (5,872,982) | |
| Taxation | (8,801) | -89.888% | (87,038) | (139,708) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 101,490 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,179,270) | -20.137% | (2,728,755) | (998,421) | (1,719,950) | (5,771,492) | |
| Net Finance Costs / (Income) | 101,698 | -- | (89,291) | (47,752) | (43,210) | 48,291 | |
| Depreciation & Amortisation | -- | -- | 125,045 | 85,627 | 69,540 | 64,062 | |
| Directors' Emoluments | -- | -- | 149,448 | 119,512 | 86,072 | 112,865 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | -146.000 | -- | -188.000 | -74.000 | -146.000 | -1,724.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -1.391 | -0.227 | -1.413 | -3.023 |
| NBV per share ($) | 6.993 | -- | 7.065 | 6.259 | 3.767 | 3.636 |
| Remarks: | Real time quote last updated: 08/06/2023 13:05 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,179,270 |
| %Change | -20.137% |
| EPS / (LPS) | RMB -1.460 |
| NBV Per Share (¥) | RMB 6.993 |